Literature DB >> 7752625

Cognitive recovery with abstinence and its relationship to family history for alcoholism.

A I Drake1, N Butters, P K Shear, T L Smith, M Bondi, M Irwin, M A Schuckit.   

Abstract

OBJECTIVE: The relationship between drinking relapse and family history for alcoholism to cognitive functioning was investigated in alcoholics who completed a 28-day inpatient treatment program.
METHOD: The current study examined 144 primary alcoholics who completed a battery of cognitive tests on admission to treatment and at a 3-4 month follow-up visit. Participants were classified as either family history positive (FH+) (n = 86) or family history negative (FH-) (n = 58) based on information on alcohol dependence in first degree relatives. The subjects were further classified as drinkers (n = 56) or abstainers (n = 88) at follow-up, based upon information gathered about their drinking practices during the interval.
RESULTS: There were no differences between the groups based on family history status at admission to treatment. Comparisons made at follow-up revealed that the abstainers' (both FH+ and FH-) performance improved. The FH+ drinkers' performance was worse than that of both the FH- drinkers and the FH+ abstainers at follow-up. The poor performance of the FH+ drinkers relative to the FH- drinkers was not attributable to differences in drinking consumption during the test-retest interval.
CONCLUSIONS: These results suggest that alcoholics who maintain abstinence following treatment show improvement on cognitive testing at follow-up; both FH+ and FH- abstainers showed improvement, indicating that a positive family history of alcoholism does not impede recovery that occurs with abstinence. The most important finding, however, is that the FH+ drinkers show greater deterioration at follow-up compared to the other groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752625     DOI: 10.15288/jsa.1995.56.104

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  8 in total

1.  Short-term neuropsychological recovery in clients with substance use disorders.

Authors:  Marsha E Bates; Gerald T Voelbel; Jennifer F Buckman; Erich W Labouvie; Danielle Barry
Journal:  Alcohol Clin Exp Res       Date:  2005-03       Impact factor: 3.455

2.  Reduced Social Network Drinking is Associated with Improved Response Inhibition in Women During Early Recovery from Alcohol Use Disorders: A Pilot Study.

Authors:  Vivia V McCutcheon; Douglas A Luke; Christina N Lessov-Schlaggar
Journal:  Alcohol Clin Exp Res       Date:  2015-12-21       Impact factor: 3.455

3.  Current Heavy Alcohol Consumption is Associated with Greater Cognitive Impairment in Older Adults.

Authors:  Adam J Woods; Eric C Porges; Vaughn E Bryant; Talia Seider; Assawin Gongvatana; Christopher W Kahler; Suzanne de la Monte; Peter M Monti; Ronald A Cohen
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

Review 4.  Neuroimmune basis of alcoholic brain damage.

Authors:  Fulton T Crews; Ryan P Vetreno
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

5.  Heavy Alcohol Use and Age Effects on HIV-Associated Neurocognitive Function.

Authors:  Ronald A Cohen; Joseph M Gullett; Eric C Porges; Adam J Woods; Damon G Lamb; Vaughn E Bryant; Mikayla McAdams; Karen Tashima; Robert Cook; Kendall Bryant; Mollie Monnig; Christopher W Kahler; Peter M Monti
Journal:  Alcohol Clin Exp Res       Date:  2018-12-16       Impact factor: 3.455

Review 6.  Impairments of brain and behavior: the neurological effects of alcohol.

Authors:  M Oscar-Berman; B Shagrin; D L Evert; C Epstein
Journal:  Alcohol Health Res World       Date:  1997

Review 7.  Neuropsychological responses in COA's.

Authors:  S J Nixon; L J Tivis
Journal:  Alcohol Health Res World       Date:  1997

8.  Family history of substance use disorders: Significance for mental health in young adults who gamble.

Authors:  Jon E Grant; Samuel R Chamberlain
Journal:  J Behav Addict       Date:  2020-06-05       Impact factor: 6.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.